Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Acta Parasitologica

4 Issues per year


IMPACT FACTOR 2017: 1.039
5-year IMPACT FACTOR: 1.121

CiteScore 2017: 1.17

SCImago Journal Rank (SJR) 2017: 0.641
Source Normalized Impact per Paper (SNIP) 2017: 0.738

Online
ISSN
1896-1851
See all formats and pricing
More options …
Volume 63, Issue 4

Issues

Low rates of Plasmodium falciparum Pfcrt K76T mutation in three sentinel sites of malaria monitoring in Côte d’Ivoire

Abibatou Konaté
  • Corresponding author
  • Department of Parasitology, Mycology, Animal Biology and, Zoology, Felix Houphouët-Boigny University, BPV 34, Abidjan, Côte d’Ivoire
  • Malaria Research and Control Centre/National Institute of Public Health, Abidjan, Côte d’Ivoire, BPV 47, Abidjan, Côte d’Ivoire
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Paterne Akpa Gnagne
  • Malaria Research and Control Centre/National Institute of Public Health, Abidjan, Côte d’Ivoire, BPV 47, Abidjan, Côte d’Ivoire
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Valérie Akoua Bédia-Tanoh
  • Department of Parasitology, Mycology, Animal Biology and, Zoology, Felix Houphouët-Boigny University, BPV 34, Abidjan, Côte d’Ivoire
  • Malaria Research and Control Centre/National Institute of Public Health, Abidjan, Côte d’Ivoire, BPV 47, Abidjan, Côte d’Ivoire
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mireille Amiah-Droh
  • Malaria Research and Control Centre/National Institute of Public Health, Abidjan, Côte d’Ivoire, BPV 47, Abidjan, Côte d’Ivoire
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Dominique Konan Tano
  • Malaria Research and Control Centre/National Institute of Public Health, Abidjan, Côte d’Ivoire, BPV 47, Abidjan, Côte d’Ivoire
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Hervé Ignace Eby Menan
  • Department of Parasitology, Mycology, Animal Biology and, Zoology, Felix Houphouët-Boigny University, BPV 34, Abidjan, Côte d’Ivoire
  • Parasitology and Mycology Laboratory of the Diagnosis and Research Centre on AIDS and the others infectious diseases, 01 BPV 13, Abidjan, Côte d’Ivoire
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ William Yavo
  • Department of Parasitology, Mycology, Animal Biology and, Zoology, Felix Houphouët-Boigny University, BPV 34, Abidjan, Côte d’Ivoire
  • Malaria Research and Control Centre/National Institute of Public Health, Abidjan, Côte d’Ivoire, BPV 47, Abidjan, Côte d’Ivoire
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-10-18 | DOI: https://doi.org/10.1515/ap-2018-0096

Abstract

Despite efforts to eliminate it, malaria remains a major public health concern, particularly in Côte d’Ivoire. Chloroquine (CQ) was one of the first drugs used for its treatment, but was officially withdrawn from the market in 2007 following reports of high levels of chloroquine resistance. The present study was carried out after the withdrawal of CQ and provides an update on the rates of CQ resistance in Côte d’Ivoire. Samples were collected between September 2013 and March 2014 in Abidjan and from January to May 2016 in Abengourou and San Pedro through cross-sectional studies. Parasitemia was assessed by microscopy, and single nucleotide polymorphism in the Pfcrt (codon 76) gene was analyzed by nested PCR and restriction fragment length polymorphism. A total of 343 samples were analyzed: 119, 106 and 118 were from Abidjan, Abengourou, and San Pedro, respectively. The sex ratio of patients was 0.92. The mean age of patients enrolled was 9.6 years (SD = 10.8). The geometric mean of parasite density was 21,337 parasites/μL (SD = 49,508; range, 2,000–200,000). Molecular analysis revealed 57 K76T mutants (16.6%): 33, 9, and 15 in Abidjan, Abengourou and in San Pedro, respectively. Most of these were found in patients aged ≤15 years (42/57) who had parasitemia greater than 10,000 parasites/μL (40/57). This is the first study conducted in Côte d’Ivoire reporting a decline in Pfcrt K76T mutation rate. Thus, our results indicate the importance of following up on the observed trend also at a national level.

Keywords: Malaria; Plasmodium falciparum; Pfcrt K76T; Côte d’Ivoire

References

  • Aba T.Y., Moh R., Cissé L., Yapo-Kouadio G.C., Ello F.N., Mossou C. et al. 2016. Plasmodium falciparum malaria in northern Côte d’Ivoire: prevalence in the general hospital of Tanda sanitary district. Malaria World Journal, 7, 1Google Scholar

  • Ako B.A., Offianan A.T., Johansson M., Penali L.K., Nguetta S-P.A., Sibley C.H. 2012. Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte d’Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005. Infection and Drug Resistance, 5, 113–120. CrossrefGoogle Scholar

  • Alifrangis M., Lusingu J.P., Mmbando B., Dalgaard M.B., Vestergaard L.S., Ishengoma D. et al. 2009. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. American Journal of Tropical Medicine and Hygiene, 80, 523–527Google Scholar

  • Assi S-B., Aba Y.T., Yavo J.C., Nguessan A.F., Tchiekoi N.B., San K.M. et al. 2017. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire. Malaria Journal, 16, 8. CrossrefGoogle Scholar

  • Assi S-B., Henry M-C., Rogier C., Dossou-Yovo J., Audibert M., Mathonnat J. et al. 2013. Inland valley rice production systems and malaria infection and disease in the forest region of western Côte d’Ivoire. Malaria Journal, 12, 233. CrossrefGoogle Scholar

  • Azagoh-Kouadio R., Enoh S.J., Kassi K.F., Cisse I., Sinde K.C., Couitchere L. et al. 2017. Paludisme de l’enfant : Prise en charge au CHU de Treichville. Revue Internationale des Sciences Médicales, 19, 26–30. (In French)Google Scholar

  • Balogun S.T., Sandabe U.K., Bdliya D.N., Adedeji W.A., Okon K.O., Fehintola F.A. 2016. Asymptomatic falciparum malaria and genetic polymorphisms of Pfcrt K76T and Pfmdr1 N86Y among almajirai in northeast Nigeria. Journal of Infection in Developing Countries, 10, 290–297. CrossrefGoogle Scholar

  • Bassa F.K., Ouattara M., Silué K.D., Adiossan L.G., Baikoro N., Koné S. et al. 2016. Epidemiology of malaria in the Taabo health and demographic surveillance system, south-central Côte d’Ivoire. Malaria Journal, 15, 9. CrossrefGoogle Scholar

  • Bla B.K., Yavo W., Trébissou J., Kipré R.G., Yapi F.H., N’guessan J.D. et al. 2014. Polymorphisms of the Pfatpase 6 and Pfcrt gene and their relationship with the in vitro susceptibility to dihydroartemisinin and chloroquine of Plasmodium falciparum isolates from Abobo, Côte d’Ivoire. Annals of Parasitology, 60, 259–266Google Scholar

  • Carneiro I., Roca-Feltrer A., Griffin J.T., Smith L., Tanner M., Schellenberg J.A. et al. 2010. Age-patterns of Malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One, 5, e8988. CrossrefGoogle Scholar

  • Charmot G., Amat-Roze J.M., Rodhain F., Le Bras J., Coulaud J.P. 1991. Abord géographique de la chloroquine-résistance de Plasmodium falciparum en Afrique tropicale. Annales de la Société Belge de Medecine Tropicale, 71, 187–197. (In French)Google Scholar

  • Diawara B., De Muyncka, Coulibaly A., Niangue J., Van Der S.P. 1996. Evaluation du système ivoirien de surveillance sentinelle de la chimiosensibilité des antipaludiques. Médecine tropicale, 56, 352–356. (In French)Google Scholar

  • Djaman J.A., Abouanou S., Basco L., Koné M. 2004. Limites de l’efficacité de la chloroquine et de la sulfadoxine-pyriméthamine au nord de la ville d’Abidjan (Côte d’Ivoire), étude couplée in vivo/in vitro. Santé, 14, 205–209. (In French)Google Scholar

  • Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T. et al. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein Pfcrt and evidence for their role in chloroquine resistance. Molecular Cell, 6, 861– 871Google Scholar

  • Frosch A., Venkatesan M., Laufer M.K. 2011. Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data. Malaria Journal, 10, 116. CrossrefGoogle Scholar

  • Frosch A.E.P., Laufer M.K., Mathanga D.P., Takala-Harrison S., Skarbinski J., Claassen C.W. et al. 2014. Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi. Journal of Infectious Diseases, 210, 1110–1114Google Scholar

  • Geiger C., Agustar H.K., Compaoré G., Coulibaly B., Sié A., Becher H. et al. 2013. Declining malaria parasite prevalence and trends of asymptomatic parasitaemia in a seasonal transmission setting in north-western Burkina Faso between 2000 and 2009–2012. Malaria Journal, 12, 27. CrossrefGoogle Scholar

  • Granado S., Manderson L., Obrist B., Tanner M. 2011. Appropriating "malaria": local responses to malaria treatment and prevention in Abidjan, Côte d’Ivoire. Medical Anthropology, 30, 102–121Google Scholar

  • Kiarie W.C., Wangai L., Agola E., Kimani F.T., Hungu C. 2015. Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker pfcrt-7613 years after cessation of chloroquine use in Msambweni, Kenya. Malaria Journal, 14, 328. CrossrefGoogle Scholar

  • Kublin J.G., Cortese J.F., Njunju E.M., Mukadam R.A., Wirima J.J., Kazembe P.N. et al. 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Journal of Infectious Diseases, 187, 1870–1875. CrossrefGoogle Scholar

  • Laufer M.K., Plowe C.V. 2004. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies. Drug Resistance Updates, 7, 279–288. CrossrefGoogle Scholar

  • Laufer M.K., Takala-Harrison S., Dzinjalamala F.K., Stine O.C., Taylor T.E., Plowe C.V. 2010. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. Journal of Infectious Diseases, 202, 801–808. CrossrefGoogle Scholar

  • Mbogo G.W., Nankoberanyi S., Tukwasibwe S., Baliraine F.N., Nsobya S.L., Conrad M.D. et al. 2014. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. American Journal of Tropical Medicine and Hygiene, 91, 54– 61. CrossrefGoogle Scholar

  • Menan E.I., Yavo W., Oga S.S., Evi J.B., Kiki-Barro P.C., Kassi R.R. et al. 2007. Open radomized study comparing chloroquine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in children in Aboisso, Cote d’ Ivoire. Médecine tropicale, 67, 309–310Google Scholar

  • Ministère de la Santé et de la Lutte contre le SIDA. 2013. Revue des performances du Programme National de Lutte contre le Paludisme. PNLP, Abidjan, Côte d’Ivoire. (In French)Google Scholar

  • Ministère de la Santé et de la Lutte contre le SIDA. 2015. Plan stratégique national de lutte contre le paludisme 2012-2015 révisé (période replanifiée): Approche stratifiée de mise à échelle des interventions de lutte contre le paludisme en Côte d’Ivoire et consolidation des acquis. PNLP, Abidjan, Côte d’Ivoire. (In French)Google Scholar

  • Ministère de la Santé et de l’Hygiène Publique. 2007. Arrêté n°24/CAB/MSHP du 12 janvier 2007 portant institution d’un schéma thérapeutique pour traitement du paludisme en Côte d’Ivoire. PNLP, Abidjan, Côte d’Ivoire. (In French)Google Scholar

  • Ministry of Health. 2015. Malawi Standard Treatment Guidelines (MSTG) 5th Edition 2015. Ministry of Health, Malawi, pp.58Google Scholar

  • Morris U., Xu W., Msellem M.I., Schwartz A., Abass A., Shakely D. et al. 2015. Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005–2013. Infection, Genetics and Evolution, 33, 110–117. CrossrefGoogle Scholar

  • Mwai L., Ochong E., Abdirahman A., Kiara S.M., Ward S., Kokwaro G. et al. 2009. Chloroquine resistance before and after its withdrawal in Kenya. Malaria Journal, 8, 106–115. CrossrefGoogle Scholar

  • Mwanza S., Joshi S., Nambozi M., Chileshe J., Malunga P., Kabuya J-B.B. et al. 2016. The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia. Malaria Journal, 15, 584. CrossrefGoogle Scholar

  • Ndiaye M., Faye B., Tine R., Ndiaye J.L., Lo A., Abiola A. et al. 2012. Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal. American Journal of Tropical Medicine and Hygiene, 87, 640–645. CrossrefGoogle Scholar

  • Nicoulet I., Simon F., Le Bras J. 1987. Apparition de chloroquinorésistance à Plasmodium falciparum en Côte-d’Ivoire. Bulletin épidémiologique hebdomadaire, 41, 163. (In French)Google Scholar

  • Ouattara L., Bla K.B., Assi S.B., Yavo W., Djaman AJ. 2010. PFCRT and DHFR-TS Sequences for Monitoring Drug Resistance in Adzopé Area of Côte d’Ivoire After the Withdrawal of Chloroquine and Pyrimethamine. Tropical Journal of Pharmaceutical Research, 9, 565–572Google Scholar

  • Sondo P., Derra K., Tarnagda Z., Nakanabo S.D., Zampa O., Kazienga A. et al. 2015. Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso. Pan African Medical Journal, 21, 101Google Scholar

  • Trape J.F., Pison G., Preziosi M.P., Enel C., Desgrées du Loû A., Delaunay V. et al. 1998. Impact of chloroquine resistance on malaria mortality. Comptes rendus de l’Académie des sciences. Série III, 321, 689–697Google Scholar

  • Trape J.F. 2001. The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene, 64(1–2 Suppl), 12–17Google Scholar

  • White N.J., Pukrittayakamee S., Hien T.T., Faiz M.A., Mokuolu O.A., Dondorp A.M. 2014. Malaria. Lancet, 383, 723–735. CrossrefGoogle Scholar

  • World Health Organization. 2017. World Malaria Report. Geneva: World Health OrganizationGoogle Scholar

  • Yavo W., Konate A., Kassi F.K., Djohan V., Angora E.K., Kiki-Barro P.C. et al. 2015. Efficacy and safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sentinel sites across Côte d’Ivoire. Malaria Research and Treatment, 878132, 8. CrossrefGoogle Scholar

About the article

Received: 2018-04-12

Revised: 2018-07-05

Accepted: 2018-08-21

Published Online: 2018-10-18

Published in Print: 2018-12-19


Conflicts of interests. The authors declare that they have no competing interests.

Authors’ contributions. YW, MEIH supervised the study. A-DM, TKD, B-TAV, GAP, and KA supervised the samples collection. KA and GAP done molecular analysis. KA analysed the data and wrote this paper. All authors contributed to the drafting of the manuscript.


Citation Information: Acta Parasitologica, Volume 63, Issue 4, Pages 795–801, ISSN (Online) 1896-1851, ISSN (Print) 1230-2821, DOI: https://doi.org/10.1515/ap-2018-0096.

Export Citation

© 2018 W. Stefański Institute of Parasitology, PAS.Get Permission

Comments (0)

Please log in or register to comment.
Log in